KDM5B and breast cancer: Research has found that KDM5B and ETS-1 jointly recruit EMSY to the coding anti-metastatic microRNA miR-31 promoter to reduce miR-31 expression, thus promoting invasive and migratory characteristics by inducing the transformation of BC cells [128].